The name Wegovy originates from "way" and "go," and "v" for a cardiovascular benefit, reflecting its intended use for weight management and its potential impact on cardiovascular health. [1]
What is Wegovy prescribed for?
Wegovy (semaglutide) is a prescription medication approved for chronic weight management in adults who are overweight or obese and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It is also approved for adolescents aged 12 years and older who weigh over 132 pounds (60 kg) and have obesity. [1]
How does Wegovy work?
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking the GLP-1 hormone, which plays a role in regulating appetite and blood sugar. By activating GLP-1 receptors in the brain, Wegovy helps to reduce hunger and increase feelings of fullness, leading to a decrease in calorie intake and subsequent weight loss. [1]
Who manufactures Wegovy?
Novo Nordisk, a Danish multinational pharmaceutical company, manufactures Wegovy. [1]
When did Wegovy become available?
Wegovy was approved by the U.S. Food and Drug Administration (FDA) in June 2021 for chronic weight management. [1]